Last update 01 Nov 2024

Atorvastatin/Fimasartan

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Atorvastatin/BR-A 657, Fimasartan/atorvastatin
Target
AT1R x HMG-CoA reductase
Mechanism
AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors)
Therapeutic Areas
Cardiovascular DiseasesEndocrinology and Metabolic Disease
Active Indication
DyslipidemiasHypertension
Inactive Indication
Hyperlipidemias
Originator Organization
Boryung Corp.Boryung Corp.
Active Organization
Boryung Corp.Boryung Corp.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
KR (14 Sep 2021),
Hypertension
Regulation-
Login to view timeline

Structure

Molecular FormulaC66H76CaF2N4O13
InChIKeyHIZONJHAVINWOX-NIJVSVLQSA-N
CAS Registry344423-98-9
View All Structures (2)

Related

2
Clinical Trials associated with Atorvastatin/Fimasartan
NCT02994745 / CompletedPhase 1
A Randomized, Open-label, Single Dose, 3x3 Partial Replicated Crossover Study to Evaluate the Pharmacokinetics and Safety/Tolerability Between a Fixed Dose Combination of Fimasartan 120mg/Atorvastatin 40mg and Co-administration of Fimasartan 120mg and Atorvastatin 40mg in Healthy Male Volunteers.
NCT02566187 / CompletedPhase 1
A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet
100 Clinical Results associated with Atorvastatin/Fimasartan
Login to view more data
100 Translational Medicine associated with Atorvastatin/Fimasartan
Login to view more data
100 Patents (Medical) associated with Atorvastatin/Fimasartan
Login to view more data
100 Deals associated with Atorvastatin/Fimasartan
Login to view more data

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Dyslipidemias
KR
Boryung Corp.Boryung Corp.
23 Sep 2021
Hypertension
KR
Boryung Corp.Boryung Corp.
14 Sep 2021
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
DyslipidemiasPhase 3-
Boryung Corp.Boryung Corp.
-
HypertensionPhase 3-
Boryung Corp.Boryung Corp.
-
HyperlipidemiasDiscovery
KR
Boryung Corp.Boryung Corp.
23 Dec 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free